The Data Everybody's Talking About: Proof FDA is More Conservative?

Approval letters are down, "approvable" and "non-approvable" letters are up. "Black box" warnings have seen a four-fold increase over the last five years. Biopharma executives are now drawing their own conclusions about the state of FDA regulation-based on the numbers.

By Ramsey Baghdadi

Is it tougher to get drugs through the Food and Drug Administration than ever before? That is the question executives...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet